Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (41-50 of 858) with videos related to

Pageof 86
Sort By:
Clinical Cornerstone|May 5, 2009
Cardiovascular disease and modifiable cardiometabolic risk factorsChristopher P Cannon
The American Journal of Managed Care|April 27, 2011
An overview of stroke and the impact of atrial fibrillationChristopher P Cannon
European Heart Journal|October 10, 2015
Should all surgery patients get statins pre-operatively? Clear or blurry VISION?Christopher P Cannon
The Journal of Family Practice|March 22, 2021
An Update on Aspirin for Cardioprevention: Implications for Patient CareChristopher P Cannon
Journal of the American College of Cardiology|March 20, 2003
Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trialChristopher P Cannon
Circulation|September 25, 2002
Evidence-based risk stratification to target therapies in acute coronary syndromesChristopher P Cannon
Clinical Cardiology|August 16, 2003
Oral platelet glycoprotein IIb/IIIa receptor inhibitors--Part IChristopher P Cannon
Reviews in Cardiovascular Medicine|October 18, 2003
Critical pathways for acute myocardial infarctionChristopher P Cannon
European Heart Journal|March 24, 2022
Statin intolerance: how common is it and how do we work with patients to overcome it?Christopher P Cannon
European Heart Journal|September 3, 2004
Revascularisation for everyone?Christopher P Cannon
Pageof 86

Showing results (41-50 of 858) with videos related to

Sort By:
Pageof 86
Clinical Cornerstone|May 5, 2009
Cardiovascular disease and modifiable cardiometabolic risk factorsChristopher P Cannon
The American Journal of Managed Care|April 27, 2011
An overview of stroke and the impact of atrial fibrillationChristopher P Cannon
European Heart Journal|October 10, 2015
Should all surgery patients get statins pre-operatively? Clear or blurry VISION?Christopher P Cannon
The Journal of Family Practice|March 22, 2021
An Update on Aspirin for Cardioprevention: Implications for Patient CareChristopher P Cannon
Journal of the American College of Cardiology|March 20, 2003
Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trialChristopher P Cannon
Circulation|September 25, 2002
Evidence-based risk stratification to target therapies in acute coronary syndromesChristopher P Cannon
Clinical Cardiology|August 16, 2003
Oral platelet glycoprotein IIb/IIIa receptor inhibitors--Part IChristopher P Cannon
Reviews in Cardiovascular Medicine|October 18, 2003
Critical pathways for acute myocardial infarctionChristopher P Cannon
European Heart Journal|March 24, 2022
Statin intolerance: how common is it and how do we work with patients to overcome it?Christopher P Cannon
European Heart Journal|September 3, 2004
Revascularisation for everyone?Christopher P Cannon
Pageof 86